◀ Back to SLC22A3
SLC22A3 — TCF7
Text-mined interactions from Literome
Peinado et al., EMBO J 2005
(Carcinoma) :
The
transcription factor Snail
controls epithelial-mesenchymal transitions (EMT) by repressing E-cadherin expression and other epithelial genes
McKeithen et al., Prostate 2010
:
Snail
transcription factor induces
epithelial-mesenchymal transition (EMT) via decreased cell adhesion associated molecules like E-cadherin, and increased mesenchymal markers like vimentin
Namba et al., Cell Death Differ 2010
(Pulmonary Fibrosis) :
Smad interacting protein 1 ( a
transcription factor regulating
EMT ) and the Notch signaling pathway but not transforming growth factor-ß was shown to be involved in A771726 induced EMT-like phenotypes
Baritaki et al., Cell cycle (Georgetown, Tex.) 2010
(Neoplasms...) :
EMT induction is mediated, in part, by the constitutive activation of the metastasis-inducer
transcription factor , Snail and
EMT can be
inhibited by the metastasis-suppressor Raf-1 kinase inhibitor protein (RKIP) and E-cadherin
Neal et al., Cell Adh Migr 2011
(Prostatic Neoplasms) :
Snail
transcription factor induces
epithelial-mesenchymal transition (EMT) in which the epithelial cells downregulate cell-cell adhesion genes such as E-Cadherin and upregulate mesenchymal genes such as vimentin, leading to increased invasion and migration
Tang et al., Int J Cancer 2012
(Pancreatic Neoplasms) :
Furthermore, EGCG
inhibited EMT by inhibiting the expression of Snail, Slug and ZEB1, and
TCF/LEF transcriptional activity, which correlated with significantly reduced CSC 's migration and invasion, suggesting the blockade of signaling involved in early metastasis
Anastassiou et al., BMC cancer 2011
(Neoplasm Invasiveness...) :
We found that human, but not mouse, cells express the signature and Slug is the only upregulated
EMT inducing
transcription factor
Shimoda et al., BMC cancer 2012
(Carcinoma, Adenoid Cystic...) :
Surprisingly, shRNA silencing of the T-box
transcription factor Brachyury ( also a differentiation marker )
resulted in downregulation of the
EMT and stem cell markers
Zhu et al., Int J Oncol 2013
(Carcinoma, Transitional Cell...) :
In conclusion that FOXQ1 may be a novel
EMT inducing
transcription factor through controlling the expression of E-cadherin and aggressiveness of cancer cells and targeting the transcription factor FOXQ1 could hence serve as a novel therapeutic strategy for cancer patients